You are here: Industry Insights > BioNTech

News List

Germany approves trials of COVID-19 vaccine candidate expresspharma
April 23, 2020
The trial, only the fourth worldwide of a vaccine targeting the virus, will be initially conducted on 200 healthy people, with more subjects, including some at higher risk from the disease, to be included in a second stage, German vaccines regulator the P
Pfizer Advances Battle Against COVID-19 on Multiple Fronts contractpharma
April 14, 2020
Pfizer has released an update on important advances in the battle against the global COVID-19 pandemic.
Pfizer finds COVID-19 drug candidate, plots summer testing fiercebiotech
April 13, 2020
Pfizer has found a leading experimental drug candidate against SARS-CoV-2 and is planning to test the drug in the coming months.
BioNTech signs Covid-19 vaccine deals with Pfizer and Fosun pharmaceutical-technology
March 18, 2020
German biotechnology firm BioNTech has partnered with Pfizer to jointly develop and distribute a potential mRNA-based Covid-19 vaccine.
Pfizer, BioNTech to co-develop potential coronavirus vaccine expresspharma
March 18, 2020
US drugmaker Pfizer has signed a deal with Germany’s BioNTech to co-develop a potential vaccine for the coronavirus using BioNTech’s mRNA-based drug development platform.
BioNTech teams up with Fosun Pharma to test Covid-19 mRNA vaccine in China — and scores $50M investment endpts
March 17, 2020
Having quietly launched its own mRNA vaccine efforts against the novel coronavirus to match the higher profile campaigns of Moderna and CureVac ...
BioNTech Reports Progress on COVID-19 Vaccine Program contractpharma
March 17, 2020
Partnered with Fosun in China and Pfizer elsewhere; anticipates start of clinical testing for vaccine in late April 2020.
BioNTech secures $325m in series B funding pharmaceutical-technology
July 11, 2019
German company BioNTech has raised $325m in a series B financing round to support further development of its therapeutics pipeline and manufacturing infrastructure.
Sanofi invests €80M in BioNTech as cancer mRNA hits clinic fiercebiotech
January 07, 2019
Sanofi is set to invest €80 million ($91 million) in BioNTech and extend its cancer collaboration with the German mRNA specialist. The agreement comes as BioNTech and Sanofi prepare to .....
Europe's biggest private biotech company raises $270 million biospectrumasia
December 24, 2018
Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to support its work in developing personalized immunotherapies for cancer, ahead of an expected eventual stock market flotation.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page